BlinkLab LimitedASX: BB1

BlinkLab Receives $1.22 Million R&D Tax Incentive Refund

· Issued by BlinkLab Limited via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

BlinkLab Limited has announced the receipt of a significant refund under the Australian Government’s R&D Tax Incentive program, which supports its ongoing research efforts. The refund is linked to the completion of a U.S. pilot study and the initiation of a pivotal program, along with clinical research collaborations in Australia. With a strong cash balance, BlinkLab is well-positioned to advance its pivotal study and seek FDA approval, which is crucial for entering the U.S. market. The funding will be utilized for further research and development activities, including clinical studies and regulatory processes.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX:BB1 ASX Announcement 19 November 2026 BlinkLab Receives $1.22 Million R&D Tax Incentive Refund Highlights ? $1,219,737 R&D Tax Incentive refund received. This non-dilutive funding comes on top of the $16.2 million cash balance reported at the end of the September 2026 quarter. ? The refund...

BlinkLab Limited on 6ix

Earlier from BlinkLab

Later from BlinkLab

All BlinkLab news releases